Research suggests that Byetta might increase a patient’s risk for thyroid cancer. In 2009, U.S. health regulators asked the drug’s manufacturer to undertake studies in order to evaluate this and other possible Byetta side effects.
The attorneys at Bernstein Liebhard LLP are investigating the potential link between Byetta and thyroid cancer. If you or a loved one developed this disease while using Byetta to treat Type 2 diabetes, please call (888) 994-5118 to learn more about your possible legal options.
The thyroid is a gland located in the neck that, among other things, produces hormones that regulate the way the body uses energy. Thyroid cancer is one of the more uncommon cancers, though it occurs more frequently in women than in men. It is also one of the most treatable cancers, and the prognosis for most people who have thyroid cancer is good. Thyroid cancer is treated with surgery and often with radioactive iodine.
Symptoms associated with thyroid cancer include:
There are several types of thyroid cancer:
In 2009, the FDA announced that it was requiring Byetta’s manufacturer to conduct six post-marketing studies in order to investigate the drug’s side effects, including a possible link to thyroid cancer.
A study published in 2011 by the journal Gastroenterology revealed that 30 cases of thyroid cancer involving Byetta patients had been reported to the U.S. Food & Drug Administration (FDA) from 2004 to 2009. The analysis suggested that the drug could increase a patient’s risk for thyroid cancer by 4.7-fold.
A 2012 study published in Experimental Diabetes Research found that Byetta increased the number of cancerous cells in the thyroids of mice.
Byetta patients may qualify to file a lawsuit if they were diagnosed with thyroid cancer while using this Type 2 diabetes medication. To obtain a free, no-obligation review of your case, please contact Bernstein Liebhard LLP today at (888) 994-5118.
Get the latest news and litigation updates about this case by following us on Facebook. Click the "Like" button below.